Literature DB >> 33586506

Postpartum Marijuana Use, Perceptions of Safety, and Breastfeeding Initiation and Duration: An Analysis of PRAMS Data From Seven States, 2017.

Kelsey C Coy1,2, Sarah C Haight1, Erica Anstey3, Althea M Grant4,5, Nan Ruffo1,6, Jean Y Ko1,5.   

Abstract

BACKGROUND: Little is known about breastfeeding initiation and duration in the context of postpartum marijuana use and safety beliefs. RESEARCH AIMS: (1) To describe characteristics of women who used marijuana postpartum; (2) to evaluate the relationship between postpartum marijuana use and breastfeeding behaviors; and 3) to assess, among women who used marijuana postpartum, how safety perceptions are associated with breastfeeding behaviors.
METHODS: Data from the cross-sectional Pregnancy Risk Assessment Monitoring System, a United States national governmental survey, 2017, were analyzed for participants with infants aged ≥ 12 weeks (seven states, unweighted N = 4604). Chi-square tests were used to compare characteristics and counseling for postpartum marijuana use. For participants with postpartum use, adjusted prevalence ratios (aPR) were calculated to evaluate relationships between safety perceptions and breastfeeding initiation and duration.
RESULTS: Overall, 5.5% (95% CI [4.6, 6.6]) of participants reported postpartum marijuana use; among these women, 47.2% (CI [37.6, 56.9]) were breastfeeding at the time of the survey. Overall, 25.7% of participants indicated that they had been advised, by their prenatal care provider, against marijuana use while breastfeeding. Breastfeeding initiation or duration did not differ by postpartum marijuana use. Among participants with postpartum use, those who perceived marijuana was safe for breastfeeding women to use were more likely to have breastfed (aPR = 1.22, CI [1.04, 1.43]) and have a breastfeeding duration > 12 weeks (aPR = 1.57, CI [1.08, 2.27]) compared to those who perceived it to be unsafe.
CONCLUSIONS: Understanding maternal safety beliefs and provider education about the latest evidence and guidance related to postpartum marijuana use may improve clinical care.

Entities:  

Keywords:  breastfeeding; breastfeeding duration; breastfeeding initiation; lactation counseling; maternal behavior; postnatal

Mesh:

Year:  2021        PMID: 33586506      PMCID: PMC8361861          DOI: 10.1177/0890334421993466

Source DB:  PubMed          Journal:  J Hum Lact        ISSN: 0890-3344            Impact factor:   2.219


  29 in total

Review 1.  ABM clinical protocol #21: guidelines for breastfeeding and substance use or substance use disorder, revised 2015.

Authors:  Sarah Reece-Stremtan; Kathleen A Marinelli
Journal:  Breastfeed Med       Date:  2015-04       Impact factor: 1.817

Review 2.  Human cannabinoid pharmacokinetics.

Authors:  Marilyn A Huestis
Journal:  Chem Biodivers       Date:  2007-08       Impact factor: 2.408

3.  Marijuana use during and after pregnancy and association of prenatal use on birth outcomes: A population-based study.

Authors:  Jean Y Ko; Van T Tong; Jennifer M Bombard; Donald K Hayes; John Davy; Katherine A Perham-Hester
Journal:  Drug Alcohol Depend       Date:  2018-03-29       Impact factor: 4.492

Review 4.  Marijuana Use in Pregnancy and While Breastfeeding.

Authors:  Torri D Metz; Laura M Borgelt
Journal:  Obstet Gynecol       Date:  2018-11       Impact factor: 7.661

5.  Marijuana: prenatal and postnatal exposure in the human.

Authors:  K Tennes; N Avitable; C Blackard; C Boyles; B Hassoun; L Holmes; M Kreye
Journal:  NIDA Res Monogr       Date:  1985

6.  Self-report of illicit substance use versus urine toxicology results from at-risk pregnant women.

Authors:  Kimberly A Yonkers; Heather B Howell; Nathan Gotman; Bruce J Rounsaville
Journal:  J Subst Use       Date:  2011-10-01

7.  Marijuana Use During Pregnancy and Breastfeeding: Implications for Neonatal and Childhood Outcomes.

Authors:  Sheryl A Ryan; Seth D Ammerman; Mary E O'Connor
Journal:  Pediatrics       Date:  2018-08-27       Impact factor: 7.124

8.  Marijuana Use by Breastfeeding Mothers and Cannabinoid Concentrations in Breast Milk.

Authors:  Kerri A Bertrand; Nathan J Hanan; Gordon Honerkamp-Smith; Brookie M Best; Christina D Chambers
Journal:  Pediatrics       Date:  2018-09       Impact factor: 7.124

9.  Pregnant Women's Current and Intended Cannabis Use in Relation to Their Views Toward Legalization and Knowledge of Potential Harm.

Authors:  Katrina Mark; Jan Gryczynski; Ellen Axenfeld; Robert P Schwartz; Mishka Terplan
Journal:  J Addict Med       Date:  2017 May/Jun       Impact factor: 3.702

10.  Surveying Lactation Professionals Regarding Marijuana Use and Breastfeeding.

Authors:  Cecilia L Bergeria; Sarah H Heil
Journal:  Breastfeed Med       Date:  2015-08-07       Impact factor: 1.817

View more
  4 in total

1.  Academy of Breastfeeding Medicine Clinical Protocol #2: Guidelines for Birth Hospitalization Discharge of Breastfeeding Dyads, Revised 2022.

Authors:  Adrienne E Hoyt-Austin; Laura R Kair; Ilse A Larson; Elizabeth K Stehel
Journal:  Breastfeed Med       Date:  2022-03       Impact factor: 2.335

2.  Breastfeeding Initiation and Continuation Among Women with Substance and Tobacco Use During Pregnancy: Findings from the Pregnancy Risk Assessment Monitoring System 2016-2018.

Authors:  Nichole Nidey; Kathleen Groh; Alicia Agnoli; Christine Wilder; Tanya E Froehlich; Stephanie Weber; Laura R Kair
Journal:  Breastfeed Med       Date:  2022-04-26       Impact factor: 2.335

Review 3.  Measuring cannabis-related knowledge, attitudes, perceptions, motivations, and influences among women of reproductive age: a scoping review.

Authors:  Kara R Skelton; Erin Donahue; Sara E Benjamin-Neelon
Journal:  BMC Womens Health       Date:  2022-03-27       Impact factor: 2.809

Review 4.  Pregnant People's Perspectives On Cannabis Use During Pregnancy: A Systematic Review and Integrative Mixed-Methods Research Synthesis.

Authors:  Meredith Vanstone; Janelle Panday; Anuoluwa Popoola; Shipra Taneja; Devon Greyson; Sarah D McDonald; Rachael Pack; Morgan Black; Beth Murray-Davis; Elizabeth Darling
Journal:  J Midwifery Womens Health       Date:  2022-04-20       Impact factor: 2.891

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.